Upsher-Smith launches generic Cyclosporine Ophthalmic Emulsion 0.05%

BioMarin Pharmaceutical meets primary endpoint in Phase 3 study of VOXZOGO in children with hypochondroplasia

Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio

Implantica submits final FDA response for RefluxStop PMA application

FDA approves MEKanistic Therapeutics' IND for MTX-531

Matter Bio submits first IND application for Lm-LLO-TT

Hansa Biopharma signs EUR115m IDEFIRIX licensing deal with SERB

Lupin receives tentative FDA approval for Revefenacin Inhalation Solution

Artivion completes acquisition of Endospan following FDA approval of NEXUS Aortic Arch System

AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension

Akeso reports results from Phase II trial of ligufalimab combination therapy in AML

US FDA approves Datar Cancer Genetics' comprehensive genomic profiling assay for solid tumours

US FDA approves Lupin's Famotidine Injection USP

Kelun-Biotech's SKB118 PD-1 x VEGF bispecific antibody receives Chinese regulatory Investigational New Drug approval

Servier's Emi-Le receives US FDA breakthrough therapy designation for adenoid cystic carcinoma